Newswire Medicare Premiums to Jump 10% Heading into 2026 December 4, 2025 Most Medicare enrollees will face premiums that are 10% higher next year, creating budget anxiety…
Newswire AI Model Could Boost Liver Transplant Efficiency by Predicting Donor Death Timing December 4, 2025 Researchers at Stanford Medicine have developed a machine learning model that significantly enhances the efficiency…
Newswire FDA Updates Sarepta’s Duchenne Gene Therapy Label, Requests Postmarketing Study December 4, 2025 The FDA has revised the label for Sarepta’s Duchenne muscular dystrophy gene therapy, Elevidys, introducing…
Newswire FDA Initiates Closed-Door Negotiations on Generic Drug User Fees December 4, 2025 The FDA and generic drug manufacturers commenced closed-door negotiations last month regarding the fourth round…
Newswire Pfizer Closes $10 Billion Metsera Deal December 4, 2025 Pfizer has finalized its acquisition of Metsera for $10 billion, a strategic move aimed at…
Newswire FDA’s Office of Generic Drugs Ensures Access to Quality Generics December 3, 2025 The FDA’s Office of Generic Drugs (OGD) plays a critical role in maintaining the integrity…
Newswire AI Meets Genetic Agency at Dyno GATC 2025 December 3, 2025 BOSTON – Artificial intelligence (AI) emerged as a pivotal theme at the recent Genetic Agency…
Newswire UK Considers Raising NICE Cost-Effectiveness Threshold Amidst Drug Spending Debate December 3, 2025 The UK is contemplating an increase in the National Institute for Health and Care Excellence…
Newswire Bristol Myers, J&J’s new blood thinner fails first big test December 3, 2025 Milvexian’s failure in acute coronary syndrome trials has raised significant concerns regarding the future of…
Newswire Advocates decry intersex exceptions in trans health bans December 3, 2025 Recent legislative measures aimed at restricting transgender healthcare have sparked significant backlash, particularly concerning the…